Urinary measurement of N-terminal B type natriuretic peptide in patients with cardiac failure - Highway or byway?;Determinación de péptido natriurético tipo B aminoterminal urinario en pacientes con insuficiencia cardiaca: ¿Autopista o carretera secundaria?

Revista Espanola de Cardiologia

Volumn 64, Issue 5, 2011, Pages 355-357

  Collinson, Paul O ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

EDITORIAL; HEART FAILURE; HUMAN;

EID: 79955579929     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2010.12.012     Document Type: Article

References (15)

1. Mant J, Doust J, Roalfe A, Barton P, Cowie MR, Glasziou P, et al. Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care. Health Technol Assess. 2009;13:1-207. iii.
2. Collinson PO. The cost effectiveness of B-Type natriuretic peptide measurement in the primary care setting-a UK perspective. Congest Heart Fail. 2006;12:103-7.
3. Michielsen EC, Bakker JA, Kimmenade RR, Pinto YM, Dieijen-Visser MP. The diagnostic value of serum and urinary NT-proBNP for heart failure. Ann Clin Biochem. 2008;45:389-94. (Pubitemid 352031546)
4. Schou M, Dalsgaard MK, Clemmesen O, Dawson EA, Yoshiga CC, Nielsen HB, et al. Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol. 2005;99:1676-80. (Pubitemid 41547162)
5. Goetze JP, Jensen G, Moller S, Bendtsen F, Rehfeld JF, Henriksen JH. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest. 2006;36:8-15.
6. Van Kimmenade RR, Januzzi Jr JL, Bakker JA, Houben AJ, Rennenberg R, Kroon AA, et al. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol. 2009;53:884-90.
7. Manzano-FernándezS, Januzzi JL,Boronat-García M, Pastor P, Albaladejo-Oton MD, Garrido IP, et al. Impact of kidney dysfunction on plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute heart failure. Congest Heart Fail. 2010;16:214-20.
8. Sharma R,GazeDC, PellerinD, Mehta RL, GregsonH, Streather CP, et al. Raised plasma N-terminal pro-B-type natriuretic peptide concentrations predict mortality and cardiac disease in end-stage renal disease. Heart. 2006;92:1518-9.
9. Ng LL, Loke IW, Davies JE, Geeranavar S, Khunti K, Stone MA, et al. Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides. J Am Coll Cardiol. 2005;45:1043-50. (Pubitemid 40432437)
10. Ng LL, Geeranavar S, Jennings SC, Loke I, O'Brien RJ. Diagnosis of heart failure using urinary natriuretic peptides. Clin Sci (Lond). 2004;106:129-33. (Pubitemid 38223430)
11. Cortes R, Portoles M, Salvador A, Bertomeu V, García DB, Martínez-Dolz L, et al. Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients. Eur J Heart Fail. 2006;8:621-7. (Pubitemid 44572958)
12. Manzano-Férnandez S, Januzzi JL, Boronat García M, Bonaque-González JC, Muñoz-Esparza C, Albaladejo-Otón MD, et al. Valor pronóstico comparativo del pro-péptido natriurético tipo B aminoterminal urinario en pacientes con desestabilización aguda de insuficiencia cardiaca. Rev Esp Cardiol. 2011;64:365-72.
13. Januzzi JL, Van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordóñez-Llanos J, Santalo-Bel M, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006;27:330-7. (Pubitemid 43100029)
14. Hildebrandt P, Collinson PO, Doughty RN, Fuat A, Gaze DC, Gustafsson F, et al. Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J. 2010;31:1881-9.
15. Lainchbury JG, Troughton RW, Strangman KM, Frampton CM, Pilbrow A, Yandle TG, et al. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol. 2009;55:53-60.